Article Tag: BioConsortia

BioConsortia, Inc. has implemented its largest proprietary field trials program to date, with hundreds of tests planned or already underway for the 2023 field season. […]

BioConsortia Inc. announced its 2022 field trial results for the company’s nematicide seed treatment products, advancing two new nematicides leads into the development pipeline, bringing […]

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30 at its Davis, CA headquarters in an investor-focused technology showcase event. BioConsortia […]

BioConsortia, Inc. and The Mosaic Company have entered into a new agreement to distribute BioConsortia’s new microbial biostimulant in Asia. The new biostimulant BEC69, branded […]

Sarah Reiter has been hired to lead BioConsortia’s business development, as the company moves towards registration and product launch for multiple products. Reiter will spearhead […]

BioConsortia, Inc. has moved two new nematicides into its development and registration phase. The new products control nematode pests and increase crop yields. In 2021 […]

The Mosaic Company and BioConsortia, Inc. have extended their agreement (see 2BMonthly December 2020), and agreed to develop and launch nitrogen-fixing microbial products for all […]

Nancy Vosnidou joins BioConsortia in the newly created position of IP and portfolio strategist. Vosnidou brings experience in patent portfolio development and strategy, as well […]

BioConsortia has expanded its R&D laboratories and team with a new facility in Davis, California, encompassing 15,000 square feet of laboratories and offices plus an […]

By Luke Hutson, NAI Editor-in-Chief and 2BM Editor Just because there’s a recession, don’t assume there’s a recession in news. Businesses still need to make […]

The Mosaic Company and BioConsortia, Inc. have entered into a collaboration to develop and launch nitrogen-fixing microbial products for corn, wheat and other major non-legume […]

Dr. Damian Curtis has joined BioConsortia, Inc. as director of synthetic biology and genomics. He will lead new technology development in strain improvement and engineering for […]

BioConsortia, Inc. has added a wheat seed treatment to the growing list of new biological products moving to registration phase. The new wheat product comes […]

BioConsortia is in the registration phase with a number of biofungicide and biostimulant products, and has a series of nematicide products that will be submitted […]

BioConsortia is moving its first products into registration phase five years after establishing its global headquarters in Davis, California. BioConsortia is focused on excellence in […]

BioConsortia, Inc. announced the promotion of Dr. Hong Zhu to Senior Vice President of Research and Development. Dr. Zhu will lead the next phase of […]

Bioconsortia closed a US$10 million round of Series D funding, led by Otter Capital and Khosla Ventures. The completion of Series D will further support […]

BioConsortia, Inc. announced that it has raised a total of $12 million this year for future growth. BioConsortia closed an $8 million equity round of […]

BioConsortia, Inc., announced the appointment of Dr. Hong Zhu to the newly formed position of Sr. Vice President of Lead Development and Manufacturing. Hong Zhu […]

When we last met for an interview in December 2013, you said you were expecting to find another exciting challenge similar to AgraQuest – “that […]

BioConsortia, Inc. announced that it has been granted a patent for its Advanced Microbial Selection (AMS) process by the U.S. Patent and Trademark Office. The […]

BioConsortia, Inc., innovator of microbial solutions for natural trait enhancement and yield improvement, announced today that it has been granted a patent for its Advanced […]

BioConsortia, Inc. has appointed Dr. Andrew Jacobs as Head of R&D for its operation in Auckland, New Zealand. He will report to Dr. Susan Turner, […]

This month marks the one year anniversary of BioConsortia, Inc., an ag biotech company which has developed a proprietary Advanced Microbial Selection (AMS) process involving […]

Flagship VentureLabs™ announces Symbiota™, after two years of development in stealth mode and a $7.5 million Series A financing from Flagship Ventures. Symbiota is pioneering […]

BioConsortia, Inc. has expanded its R & D team to include Graham Hymus PhD, Thomas Williams PhD, and Elsebeth Kolmos PhD. Each brings broad and […]

BioConsortia, Inc. opened company headquarters and R&D laboratories in Davis, California. BioConsortia has developed a R&D technology linking plant phenotype selection with high-throughput microbial screening […]

BioConsortia, Inc., has expanded its staff to include Christina Huben as senior vice president of operations and administration and Susan Turner as senior vice president […]

BioConsortia, Inc., an innovator in microbial consortia for improving plant traits and increasing crop yields, has just announced the opening of its new company headquarters […]

BioConsortia, Inc., an agricultural biotechnology company that uses a proprietary method for the selection of beneficial microbial consortia for crop improvement, has raised an additional […]

BioConsortia, Inc., an agricultural biotechnology company that uses a proprietary method for the selection of beneficial microbial consortia for crop improvement, has raised an additional […]